课题基金 / 基金详情

IMMUNE REGULATION BY IMMUNOGLOBULIN-LIKE RECEPTORS

IMMUNE REGULATION BY IMMUNOGLOBULIN-LIKE RECEPTORS
免疫球蛋白样受体的免疫调节
批准号:
14207014
负责人:
TAKAI Toshiyuki
金额:
$19.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

TAKAI Toshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
表达在B细胞和髓系细胞上的PIRS形成一种独特的“自我”识别。激活的PIR-A和抑制的PIR-B与多种小鼠MHC I类(H-2)分子结合。体外H-2四聚体刺激PIRS可诱导细胞内磷酸酪氨酸信号转导。移植异基因脾细胞的PIR-B缺陷小鼠表现出移植物抗宿主疾病的加重,这是由于受体的树突状细胞(DC)的增强激活,伴随着PIR-A的上调和干扰素的产生。Pir-A诱导的DC活化也导致供体细胞毒性T细胞的增殖增加。因此,PIR-A和PIR-B是在成功的组织移植中起关键作用的反向作用受体,在生理条件下可能以一种结构性的方式调节与自体组织无关的反应。为了分析DNAX蛋白12(DNAX Protein 12)缺陷小鼠轻度骨化症的病因,我们观察了FcRγ缺陷(Fcrγ-)和DAP12/Fcrγ双缺陷(DKO)小鼠的骨形态。组织学检查显示FCRγ--小鼠未出现明显的骨化病。然而,我们发现DKO小鼠表现出比DAP12-小鼠更严重的骨石化,这表明DAP12或FcRγ是正常骨重建所必需的。在破骨细胞前体细胞中,FcRγ和DAP12分别与OSCAR、PIR-A、TREM-2和Sirpβ1等多种Ig受体结合,并通过PLCγ激活Ca^2信号。因此,由多个IgLR激活的ITAM依赖的共刺激信号对于维持骨内环境的稳定是必不可少的,这表明RANK和M-CSF受体不足以激活破骨细胞形成所需的信号。
英文摘要
PIRs expressed on B and myeloid cells form a unique 'self' recognition. Activating PIR-A and inhibitory PIR-B were shown to bind various murine MHC class I (H-2) molecules. In vitro H-2 tetramer stimulation of PIRs induced intracellular phosphotyrosine signaling. PIR-B-deficient mice transferred with allogeneic splenocytes showed exacerbated graft-versus-host disease, which was due to the augmented activation of the recipient's dendritic cells (DCs) with the concomitant up-regulation of PIR-A and increased IFN-production. PIR-A-induced DC activation also led to increased proliferation of donor cytotoxic T cells. Thus, PIR-A and PIR-B are counter-acting receptors that play key roles for successful tissue transplantation, and may regulate irrelevant reaction to autologous tissues in a constitutive fashion under physiological circumstances.To analyze the etiology of mild osteopetrosis in DAP12 (DNAX protein 12)-deficient mice, we examined the bone morphology in FcRγ-deficient (FcRγ--) mice and DAP12/FcRγ double deficient (DKO) mice. Histological examination revealed that FcRγ--mice did not show any remarkable osteopetrosis. However, we found that DKO mice exhibited much more severe osteopetrosis than DAP12--mice, suggesting that either DAP12 or FcRγ is required for normal bone remodeling. In osteoclast precursor cells, FcRγ and DAP12 associate with multiple IgLRs including OSCAR and PIR-A ; and TREM-2 and SIRPβ1, respectively, and activate Ca^2 signal through PLCγ. Thus, ITAM-dependent costimulatory signals activated by multiple IgLRs are indispensable for the maintenance of bone homeostasis, indicating that RANK and M-CSF receptor are not sufficient to activate signals required for osteoclastogenesis.
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
Yamaguchi A et al.: "Possible role of autoantibody in the pathophysiology of GM2 angliosidoses"J.Clin.Invest.. 113(2). 200-208 (2004)
Yamaguchi A 等人:“自身抗体在 GM2 血管瘤的病理生理学中的可能作用”J.Clin.Invest.. 113(2)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1172/jci16923
发表时间: 2003-02
期刊: The Journal of clinical investigation
影响因子: --
作者: [T. Kaifu;J. Nakahara;M. Inui;K. Mishima;T. Momiyama;Mitsuji Kaji;Akiko Sugahara;H. Koito;Azusa Ujik]
通讯作者: T. Kaifu;J. Nakahara;M. Inui;K. Mishima;T. Momiyama;Mitsuji Kaji;Akiko Sugahara;H. Koito;Azusa Ujik
The pre-B cell receptor signaling for apoptosis is negatively regulated by FcgRIIB.
凋亡相关的前 B 细胞受体信号传导受到 FcgRIIB 的负向调节。
DOI: --
发表时间: 2002
期刊: J.Immunol. 168
影响因子: --
作者: [Kato I, Takai T, Kudo A.]
通讯作者: Kudo A.
Akiyama K, et al.: "Targeting of apoptotic tumor cells to Fcγ receptors provides efficient and versatile vaccination against tumors by dendritic cells"J. Immunol. 170(4). 1641-1648 (2003)
Akiyama K 等人:“将凋亡的肿瘤细胞靶向 Fcγ 受体提供了树突状细胞针对肿瘤的有效且多功能的疫苗接种”J.Immunol.170(4)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 25 条
    Mechanism of LILRB4-mediated immune checkpoint
    • 批准号:
      19H03484
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2019
    • 负责人:
      TAKAI Toshiyuki
    • 依托单位:
    Modulating immunological memory of antibody-producing cells
    • 批准号:
      17K19539
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.16万
    • 财政年份:
      2017
    • 负责人:
      TAKAI Toshiyuki
    • 依托单位:
    Identification of molecular characteristics of pathogenic autoantibody-producing cells
    • 批准号:
      16H05201
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2016
    • 负责人:
      TAKAI Toshiyuki
    • 依托单位:
    Platelets convert peripheral blood circulating monocytes to regulatory cells via immunoglobulin G and activating-type Fcg receptors.
    • 批准号:
      26670230
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2014
    • 负责人:
      TAKAI Toshiyuki
    • 依托单位:
    国内基金
    海外基金
    基于YB-1/MAPK轴的双重干预探讨SU056与piR-YB-1在TNBC中的协同作用与转化潜力
    mo_piR_017990通过m6A修饰抑制Syt11mRNA表达调控自噬小体成熟在脑缺血耐受中的作用
    piR-mmu-40423调控骨髓间充质干细胞成骨/成脂分化在老年性骨质疏松中的作用机制研究
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      王成龙
    • 依托单位:
    piR-7472 通过调节WTAP/YTHDC1 影响 m6A 修饰对继发性骨质疏松的调控作用及机制研究
    • 批准号:
      2024JJ7473
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      隆宇斌
    • 依托单位: